Karine Clément

1995–2026 年に発表

別表記
Karine Clement
306
論文数
65,268
被引用数
132
h 指数
290
i10 指数

被引用数

Karine Clément の年別被引用数1962 年: 被引用 1 件1977 年: 被引用 2 件1981 年: 被引用 1 件1983 年: 被引用 1 件1986 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 12 件1997 年: 被引用 30 件1998 年: 被引用 50 件1999 年: 被引用 96 件2000 年: 被引用 153 件2001 年: 被引用 122 件2002 年: 被引用 147 件2003 年: 被引用 183 件2004 年: 被引用 169 件2005 年: 被引用 244 件2006 年: 被引用 309 件2007 年: 被引用 265 件2008 年: 被引用 341 件2009 年: 被引用 313 件2010 年: 被引用 369 件2011 年: 被引用 447 件2012 年: 被引用 471 件2013 年: 被引用 579 件2014 年: 被引用 669 件2015 年: 被引用 837 件2016 年: 被引用 860 件2017 年: 被引用 889 件2018 年: 被引用 933 件2019 年: 被引用 2,157 件2020 年: 被引用 2,707 件2021 年: 被引用 2,838 件2022 年: 被引用 2,756 件2023 年: 被引用 2,108 件2024 年: 被引用 3,244 件2025 年: 被引用 1,829 件2026 年: 被引用 71 件1963〜1976 年は被引用が無いため表示していません1978〜1980 年は被引用が無いため表示していません1982 年は被引用が無いため表示していません1984〜1985 年は被引用が無いため表示していません1987〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,482 件、この内訳の 20.6%中国: 引用元論文 4,354 件、この内訳の 13.8%イギリス: 引用元論文 2,072 件、この内訳の 6.6%フランス: 引用元論文 1,720 件、この内訳の 5.4%ドイツ: 引用元論文 1,450 件、この内訳の 4.6%イタリア: 引用元論文 1,426 件、この内訳の 4.5%スペイン: 引用元論文 1,129 件、この内訳の 3.6%カナダ: 引用元論文 947 件、この内訳の 3%オランダ: 引用元論文 862 件、この内訳の 2.7%オーストラリア: 引用元論文 789 件、この内訳の 2.5%スウェーデン: 引用元論文 749 件、この内訳の 2.4%日本: 引用元論文 662 件、この内訳の 2.1%
0%20.6%その他 28.2%

分野

  • Medicine48.4%
  • Biochemistry, Genetics and Molecular Biology33.8%
  • Neuroscience7.2%
  • Immunology and Microbiology3.9%
  • Nursing1.8%
  • Agricultural and Biological Sciences1.4%
  • その他3.5%

トピック

  • Gut microbiota and health9.7%
  • Diet and metabolism studies5.6%
  • Adipokines, Inflammation, and Metabolic Diseases5.2%
  • Liver Disease Diagnosis and Treatment5%
  • Adipose Tissue and Metabolism4.4%
  • Regulation of Appetite and Obesity2.9%
  • その他67.2%

共著者

全論文

検索で開く
  1. Richness of human gut microbiome correlates with metabolic markers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karsten Kristiansen, Pierre Renault, Thomas Sicheritz‐Pontén, Willem M. de Vos, Jean‐Daniel Zucker, Jeroen Raes, Torben Hansen, Éric Guédon, Christine Delorme, Séverine Layec, Ghalia Khaci, Maarten van de Guchte, Gaetana Vandemeulebrouck, Alexandre Jamet, Rozenn Dervyn, Nicolás Sánchez, Emmanuelle Maguin, Florence Haimet, Yohanan Winogradski, Antonella Cultrone, Marion Leclerc, Catherine Juste, Hervé M. Blottière, Éric Pelletier, Denis LePaslier, François Artiguenave, Thomas Brüls, Jean Weissenbach, A. Keith Turner, Julian Parkhill, Maria Antolı́n, Chaysavanh Manichanh, Francesc Casellas, N. Boruel, Encarna Varela, Antonio Torrejón, Francisco Guarner, Gérard Denariaz, Muriel Derrien, Johan E. T. van Hylckama Vlieg, Patrick Veiga, Raish Oozeer, Jan Knol, María Rescigno, Christian Bréchot, Christine M’Rini, Alexandre Mérieux, Takuji Yamada, Peer Bork, Jun Wang, S. Dusko Ehrlich, Oluf Pedersen - Nature 2013 被引用: 4,803

  2. Gut microbiota-derived metabolites as central regulators in metabolic disorders

    著者: , , - Gut 2020 被引用: 1,283

  3. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

    著者: , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2020 被引用: 1,043

  4. Definition and diagnostic criteria of clinical obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Éric Ravussin, Edward W. Gregg, Noor B Al Busaidi, Nasreen Alfaris, Ebaa Al‐Ozairi, Lena Carlsson, Karine Clément, Jean‐Pierre Després, John B. Dixon, Gauden Galea, Lee M. Kaplan, Blandine Laferrère, Martine Laville, Soo Kun Lim, Jesús R Luna Fuentes, Vicki Mooney, Joseph Nadglowski, Urudinachi Nnenne Agbo, Magdalena Olszanecka‐Glinianowicz, An Pan, François Pattou, Philip R. Schauer, Matthias H. Tschöp, M. T. van der Merwe, Roberto Vettor, Geltrude Mingrone - The Lancet Diabetes & Endocrinology 2025 被引用: 1,324

  5. Contemporary medical, device, and surgical therapies for obesity in adults

    著者: , , , , - The Lancet 2023 被引用: 678

  6. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

    著者: , , , , , , , , , , , , , , - Gut 2015 被引用: 1,886

  7. Dietary intervention impact on gut microbial gene richness

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean Weissenbach, Éric Pelletier, Denis Le Paslier, Jean-Pierre Gauchi, Jean-François Gibrat, Valentin Loux, Wilfrid Carré, Emmanuelle Maguin, Maarten van de Guchte, Alexandre Jamet, Fouad Boumezbeur, Séverine Layec - Nature 2013 被引用: 1,846

  8. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 454

  9. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies

    著者: , , , - Gastroenterology 2020 被引用: 435

  10. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 514

  11. Microbiome and metabolome features of the cardiometabolic disease spectrum

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Olsson, Helle Pedersen, Nicolas Pons, Benoît Quinquis, Christine Rouault, Hugo Roume, Joe‐Elie Salem, Thomas Schmidt, Sara Vieira‐Silva, Peishun Li, Maria Zimmermann‐Kogadeeva, Christian Lewinter, Nadja B. Søndertoft, Tue H. Hansen, Dominique Gauguier, Jens Peter Gøtze, Lars Køber, Ran Kornowski, Henrik Vestergaard, Torben Hansen, Jean‐Daniel Zucker, Serge Herçberg, Ivica Letunić, Fredrik Bäckhed, Jean‐Michel Oppert, Jens Nielsen, Jeroen Raes, Peer Bork, Michael Stümvoll, Eran Segal, Karine Clément, Marc‐Emmanuel Dumas, S. Dusko Ehrlich, Oluf Pedersen - Nature Medicine 2022 被引用: 286

  12. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Esther Schulz, Egbert Voß, Nataša Bratina, Katja Weiß, Gabriel Ángel Martos‐Moreno, Alban Danset, Paul Gougis, Béatrice Dubern, Karine Clément, Erica L T van den Akker, Jesús Argente, Allison Bahm, Wendy K Chung, Hillori Connors, Kathleen De Waele, I. Sadaf Farooqi, Julie Gonneau-Lejeune, Gregory Gordon, Christine Poitou, Lia Puder, James Swain, Murray Stewart, Goujun Yuan, Martin Wabitsch, Peter Kühnen - The Lancet Diabetes & Endocrinology 2020 被引用: 463

  13. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier ほか 35 名 - Journal of Hepatology 2021 被引用: 353

  14. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  15. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

    著者: , , , - Gastroenterology 2020 被引用: 233

  16. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

    著者: , , , , , , , - Hepatology 2012 被引用: 884

  17. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars

    著者: , , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2018 被引用: 429

  18. Fibrosis and Adipose Tissue Dysfunction

    著者: , , , - Cell Metabolism 2013 被引用: 923

  19. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen ほか 138 名 - Nature Metabolism 2024 被引用: 229

  20. Krüppel-like factor 4 regulates macrophage polarization

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 被引用: 761

  21. Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain

    著者: , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 被引用: 189

  22. Risk assessment with gut microbiome and metabolite markers in NAFLD development

    著者: , , , , , , , , , , , , , , , , - Science Translational Medicine 2022 被引用: 149

  23. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 被引用: 617

  24. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period

    著者: , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2022 被引用: 182